In order to make a significant impact in targeting neglected tropical diseases, many issues are at stake and need to be addressed. Which diseases are most prevailing and which present newly emerging targets for developing therapeutics? Are there novel opportunities for collaborations? How can the communication and collaboration between the developed and the underdeveloped countries be improved and what are the most pressing issues? Can lessons learned be adapted to different countries or for different diseases? What are the current strategies pursued by consortia and collaboration efforts? And lastly – is there a good way for dealing with IP issues and concerns?
This meeting strives to bring together worldwide experts from various organizations, academia, consortia and the life science industry to discuss, brainstorm and discover novel ideas and possibilities for developing therapeutics for neglected tropical diseases.
Coverage Includes:
- Promising Therapeutic Targets and Strategies
- Case Studies of Successful Collaborations
- Drug Repositioning
- Screening for Novel Therapeutic Possibilities
- Targeting Leishmania
- Open-Access Resources
- Success and Progress in NDs, Including Malaria and TB
Stay on to attend
Indications Discovery & Drug Repositioning Summit (March 13-14, 2012)
- Data Analysis
- Pre-Clinical Testing in Disease Models
- Targeting Metabolic Pathways
- Meeting Current Regulatory Standards
- Technologies for Indication Discovery
|
- Turning “Off Target Effects” of Current Drugs into Novel Targets
- Screening in Disease Models
- Computational Approaches
- Drug Repositioning for Neglected Diseases
- Successful Case Studies for Drug Repositioning
|
Special discount is available to attend both events: Register today
|